Latest Insider Transactions at Cano Health, Inc. (CANO)
This section provides a real-time view of insider transactions for Cano Health, Inc. (CANO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cano Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cano Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Nut Tree Capital Management, LP |
BUY
Other acquisition or disposition
|
Indirect |
11,025,141
+50.0%
|
-
|
|
Jun 28
2024
|
Gil Eladio Interim CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,676
-100.0%
|
-
|
|
Jun 28
2024
|
Solomon D Trujillo |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,782
-100.0%
|
-
|
|
Jun 28
2024
|
Solomon D Trujillo |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
136,804
-100.0%
|
-
|
|
Jun 28
2024
|
Angel L Morales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,485
-100.0%
|
-
|
|
Jun 28
2024
|
Angel L Morales |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
69,685
-100.0%
|
-
|
|
Jun 28
2024
|
Robert Camerlinck Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
269,586
-100.0%
|
-
|
|
Jun 28
2024
|
David J Armstrong |
BUY
Sale (or disposition) back to the issuer
|
Direct |
6,641
+100.0%
|
-
|
|
Jun 28
2024
|
Kim M Rivera |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,485
-100.0%
|
-
|
|
Jun 28
2024
|
Mark D. Kent Interim CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
96,711
-100.0%
|
-
|
|
Jun 28
2024
|
Mark D. Kent Interim CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,296
-100.0%
|
-
|
|
Jun 28
2024
|
Alan Muney |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,485
-100.0%
|
-
|
|
Feb 01
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
1,100
-0.21%
|
$2,200
$2.53 P/Share
|
|
Jan 31
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
8,935
-1.7%
|
$17,870
$2.59 P/Share
|
|
Jan 30
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
12,703
-2.36%
|
$25,406
$2.7 P/Share
|
|
Jan 29
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
41,357
-7.13%
|
$82,714
$2.74 P/Share
|
|
Jan 26
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
32,693
-5.34%
|
$65,386
$2.74 P/Share
|
|
Jan 25
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
18,569
-2.94%
|
$37,138
$2.58 P/Share
|
|
Jan 24
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
35,808
-5.37%
|
$71,616
$2.84 P/Share
|
|
Jan 23
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
73,034
-9.87%
|
$146,068
$2.94 P/Share
|
|
Jan 22
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
125,000
-14.45%
|
$250,000
$2.5 P/Share
|
|
Jan 18
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
100,000
-10.36%
|
$100,000
$1.91 P/Share
|
|
Jan 17
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
100,000
-4.72%
|
$200,000
$2.6 P/Share
|
|
Jan 12
2024
|
Elliot Cooperstone |
BUY
Conversion of derivative security
|
Indirect |
1,065,206
+50.0%
|
-
|
|
Jan 12
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
24,171
-100.0%
|
$72,513
$3.3 P/Share
|
|
Jan 11
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-50.84%
|
$75,000
$3.59 P/Share
|
|
Jan 10
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-33.71%
|
$75,000
$3.73 P/Share
|
|
Jan 09
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-25.21%
|
$75,000
$3.75 P/Share
|
|
Jan 08
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-20.13%
|
$75,000
$3.82 P/Share
|
|
Jan 05
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
25,000
-16.76%
|
$75,000
$3.85 P/Share
|
|
Jan 04
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
13,328
-8.2%
|
$53,312
$4.0 P/Share
|
|
Jan 03
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
75,000
-17.18%
|
$300,000
$4.51 P/Share
|
|
Jan 02
2024
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
43,505
-15.48%
|
$217,525
$5.42 P/Share
|
|
Dec 29
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
35,112
-11.11%
|
$210,672
$6.0 P/Share
|
|
Dec 28
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
41,197
-11.53%
|
$247,182
$6.0 P/Share
|
|
Dec 27
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
37,607
-9.52%
|
$188,035
$5.65 P/Share
|
|
Dec 26
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
21,154
-5.08%
|
$105,770
$5.44 P/Share
|
|
Dec 22
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
27,377
-6.17%
|
$136,885
$5.65 P/Share
|
|
Dec 21
2023
|
Elliot Cooperstone |
SELL
Open market or private sale
|
Indirect |
89,152
-8.48%
|
$534,912
$6.15 P/Share
|
|
Dec 15
2023
|
Elliot Cooperstone |
BUY
Conversion of derivative security
|
Indirect |
532,603
+50.0%
|
-
|
|
Dec 07
2023
|
Solomon D Trujillo |
BUY
Conversion of derivative security
|
Indirect |
136,804
+50.0%
|
-
|
|
Nov 20
2023
|
Angel L Morales |
BUY
Conversion of derivative security
|
Indirect |
69,685
+50.0%
|
-
|
|
Nov 10
2023
|
Gil Eladio Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,676
+50.0%
|
-
|
|
Aug 11
2023
|
Robert Camerlinck Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,646
-0.11%
|
$0
$0.77 P/Share
|
|
Jul 12
2023
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
189,681
+3.7%
|
-
|
|
Jul 12
2023
|
Mark D. Kent Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,354,325
+39.12%
|
-
|
|
Jun 30
2023
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
7,506
+1.12%
|
$0
$0.77 P/Share
|
|
Jun 29
2023
|
Richard Aguilar Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
400,000
-24.78%
|
$400,000
$1.31 P/Share
|
|
Jun 28
2023
|
Richard Aguilar Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
150,000
-8.5%
|
$150,000
$1.22 P/Share
|
|
Jun 26
2023
|
Richard Aguilar Chief Clinical Officer |
BUY
Conversion of derivative security
|
Direct |
550,000
+23.77%
|
-
|